Content HUB

Our Content HUB gives you access to complimentary resources including Webinars, Market Industry Reports, Q&A Sessions, Newsletters and much more.

Journal Collaborations & Media Partners

The NextGen Omics UK marketing team work with leading journal publications on reciprocal marketing arrangements.

If you are interested in promoting your journal/association to the leading players in this industry please contact us.

Genes

Genes (ISSN 2073-4425, IF 3.331), an international, peer-reviewed open access journal on genetics and genomics who publishes reviews, research articles, communications and technical notes on the following topics of interest, but are not limited to:
• DNA; RNA
• genetic code; gene structure; gene expression
• chromosomes; recombination and linkage; genetic mapping
• transcriptional profiling; analysis of noncoding and other RNAs
• cloning; genetically modified organisms
• human genetics; medical genetics; gene therapy; personal medicine
• population genetics; conservation genetics; phylogenomics; phylogenetics
• genome projects; genomics
• sequencing technologies; bioinformatics
Genes was launched in 2010 and has published more than 2500 peer-reviewed manuscripts freely available on our website. Our journal is led by more than 300 international editorial boards covering all the fields of genetics and genomics and currently ranked 61/174 (Q2) in Journal Citation Reports® in the “Genetics & Heredity-SCIE” category.

Bentham Science

Bentham Science Publishers is a major STM journal publisher of 130 plus print and online journal. Out of these, 40 journals have already registered good IMPACT FACTORS as per Journal Citation Reports® 2017. These titles have extensive readership mostly in Europe and North America. For a detailed profile please visit our website at www.benthamscience.com. Besides, Bentham Science publishes eBooks in all areas of Science, Technology and Medicine. Our eBooks provide professionals, academicians, corporate researchers, graduates and undergraduates worldwide with the most current information in their subject areas of interest. Our eBooks are also available in the ePub and Kindle formats besides the PDF edition here ebooks.benthamscience.com. Bentham Science is offering 20% discounts on purchasing eBooks and subscriptions on Journals to delegates attending the conference. TO AVAIL, QUOTE “BSPCNF2019” at www.eurekaselect.com or email at marketing@benthamscience.net. For more information: benthamscience.com/index.php

Live Webinar

Genomic Testing Strategies For Research Through To Clinical Studies: Profiling Of Genomics From NeoGenomics' Perspective

As genomic technologies develop and mature, adoption moves from the research environment into the clinical setting.  Previously, where Sanger and qPCR were the most rational choices to commercialize a diagnostic, NGS has become the biomarker testing methodology of choice.  Additionally, other emerging technologies and platforms like NanoString are finding their way into clinical trials as well as routine diagnostics.  With advances in technology, biomarker testing strategies have also evolved with a trend toward higher order multiplexed technologies as well as cross modality testing from a single sample to understand correlations between DNA, RNA and protein markers.  More data may be over burdensome to analyze, while a focused assay may miss an opportunity for collecting potentially valuable data.  Without a straightforward “rule of thumb” for which genomics technology to use when, thoughtful consultation is required.  This presentation will discuss the various factors and consideration points for choosing a genomic biomarker testing strategy to support biomarker projects.

Presented by James Yen, Senior Scientific Manager, CDx Programs, NeoGenomics

Thursday, 25 June 2020 | 15:30 BST